List of Excipients in Branded Drug PANTOPRAZOLE SODIUM

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Hikma Pharmaceuticals USA Inc	PANTOPRAZOLE SODIUM	pantoprazole sodium	0143-9284	SODIUM HYDROXIDE
Hikma Pharmaceuticals USA Inc	PANTOPRAZOLE SODIUM	pantoprazole sodium	0143-9300	SODIUM HYDROXIDE
Baxter Healthcare Corporation	PANTOPRAZOLE SODIUM	pantoprazole sodium in 0.9% sodium chloride	0338-9644	EDETATE DISODIUM
Baxter Healthcare Corporation	PANTOPRAZOLE SODIUM	pantoprazole sodium in 0.9% sodium chloride	0338-9644	HISTIDINE
Baxter Healthcare Corporation	PANTOPRAZOLE SODIUM	pantoprazole sodium in 0.9% sodium chloride	0338-9644	SODIUM CHLORIDE

Generic Drugs Containing PANTOPRAZOLE SODIUM

Company	Ingredient	NDC	Excipient
Mylan Pharmaceuticals Inc	pantoprazole sodium	0378-6688	CALCIUM STEARATE
Mylan Pharmaceuticals Inc	pantoprazole sodium	0378-6688	CROSPOVIDONE
Mylan Pharmaceuticals Inc	pantoprazole sodium	0378-6688	FERRIC OXIDE YELLOW
Mylan Pharmaceuticals Inc	pantoprazole sodium	0378-6688	FERROSOFERRIC OXIDE
Mylan Pharmaceuticals Inc	pantoprazole sodium	0378-6688	HYPROMELLOSE

What are the Most Frequently-Used Excipients in PANTOPRAZOLE SODIUM?

# Of NDCs	Excipient
3	ALCOHOL
9	ALUMINUM OXIDE
94	AMMONIA
4	ANHYDROUS LACTOSE
44	BUTYL ALCOHOL

Excipient Strategy and Commercial Opportunities for Pantoprazole Sodium

Last updated: February 27, 2026

What are the key excipient considerations for Pantoprazole Sodium?

Pantoprazole sodium, a proton pump inhibitor (PPI), requires careful formulation to ensure stability, bioavailability, and manufacturing efficiency. The compound's sensitivity to temperature, acid, and moisture influences excipient selection, which impacts shelf life, efficacy, and patient compliance.

Critical excipient characteristics

• Enteric coating agents: Pantoprazole sodium degrades in acidic environments; enteric coatings such as hydroxypropyl methylcellulose (HPMC) or methacrylic acid copolymers (Eudragit series) prevent premature release.
• Fillers and diluents: Microcrystalline cellulose (MCC) and lactose monohydrate provide volume and stability.
• Binders and disintegrants: Croscarmellose sodium and sodium starch glycolate facilitate tablet disintegration.
• Lubricants and glidants: Magnesium stearate and colloidal silicon dioxide improve manufacturing flow and tablet integrity.

Formulation trends

Recent formulations favor hydroxypropyl methylcellulose (HPMC) for controlled-release delivery, reducing gastrointestinal irritation and improving pharmacokinetics. The excipient matrix influences the stability of the active ingredient, particularly during manufacturing and storage.

How do excipient choices impact manufacturing and regulatory compliance?

Selection of excipients affects process robustness, scale-up, and regulatory approval. Excipients must comply with pharmacopeial standards (e.g., USP, EP). Consistency in excipient quality reduces batch variability and minimizes regulatory review demands.

Regulatory considerations

• GRAS status: Excipients like MCC, lactose, and magnesium stearate are generally recognized as safe.
• Compatibility testing: Ensures no adverse interactions with pantoprazole sodium.
• Stability studies: Confirm the excipients support the drug's shelf life, particularly under variable environmental conditions.

Manufacturing considerations

• Flowability: Excipients influence powder flow, affecting tablet compression efficiency.
• Moisture sensitivity: Hygroscopic excipients must be managed to prevent degradation.
• Process flexibility: Choice of excipients can enable various manufacturing modalities such as immediate-release and controlled-release tablets or capsules.

What commercial opportunities exist through excipient innovation?

Innovative excipient strategies can lead to differentiation, patent extension, and new dosage forms. Key opportunities include:

Developing novel delivery systems

• Extended-release formulations: Using novel polymers (e.g., acrylate-based) to improve patient adherence and reduce dosing frequency.
• Oral suspensions: Employing stabilizing excipients suitable for pediatric and elderly populations.

Enhancing stability and shelf life

• Protective excipients: Incorporate antioxidants or desiccants to minimize degradation.
• Moisture barriers: Use of advanced polymers or coating materials can mitigate environmental impact.

Leveraging patent and formulation exclusivity

• Custom excipients or modified-release mechanisms create opportunities to extend patent life beyond the primary active ingredient patent expiration.

Partnering with excipient suppliers

• Securing supply chain agreements for high-quality, specialized excipients supports global manufacturing demands.

Impacts of regulatory landscapes

• The US FDA and EMA emphasize excipient transparency; approval of new excipients or formulations requires comprehensive documentation.

How does excipient strategy influence market positioning?

A robust excipient strategy improves product stability, reduces manufacturing costs, and enhances patient experience. These factors influence market share, especially in highly competitive PPIs.

Key differentiators

• Improved bioavailability: Innovative excipients can optimize absorption.
• Reduced adverse events: Careful excipient selection minimizes side effects, such as gastrointestinal discomfort.
• Simplified manufacturing: Excipients that streamline processes lower production costs, enabling competitive pricing.

Market insights

• The global proton pump inhibitors market was valued at approximately USD 12.4 billion in 2022, expected to grow at a CAGR of 3.2% through 2030 (Source: Grand View Research). Formulation improvements driven by excipient strategy can capitalize on this growth.

Key Takeaways

• Excipient selection for pantoprazole sodium must prioritize stability, bioavailability, and manufacturing efficiency.
• Novel delivery systems and formulation enhancements offer patent opportunities and differentiation.
• Regulatory compliance and supply chain reliability are critical for commercial success.
• Innovation in excipient technology supports extended patent life and competitive positioning.

FAQs

1. What excipients are most commonly used in pantoprazole sodium formulations?
   Microcrystalline cellulose, lactose, croscarmellose sodium, magnesium stearate, and enteric coating agents like Eudragit are standard.

2. How can excipient innovation extend product patent life?
   By developing unique delivery mechanisms or utilizing novel polymers, manufacturers can create formulations eligible for additional patent protection.

3. What challenges exist with excipient stability?
   Moisture sensitivity, hygroscopicity, and chemical interactions can compromise drug stability; selecting appropriate excipients reduces these risks.

4. Are there regulatory hurdles with new excipients?
   Yes. New excipients require rigorous safety and compatibility testing, as well as regulatory approval, which can delay commercialization.

5. What is the role of excipient cost in formulation strategy?
   Cost-efficient excipients help control manufacturing expenses, enabling competitive pricing without compromising quality.

---

References

[1] Grand View Research. (2022). Proton pump inhibitors market size, share & trends analysis.
[2] USP NF. (2022). United States Pharmacopeia and National Formulary.
[3] EMA. (2022). Guideline on the specification for excipients used in medicines.